Frontiers in Immunology

dc.creatorSchinnerling, Katina
dc.creatorGarcía-González, Paulina A
dc.creatorAguillón-Gutiérrez, Juan Carlos
dc.date2018-11-29T15:36:52Z
dc.date2022-07-07T15:55:40Z
dc.date2014
dc.date2018-11-29T15:36:52Z
dc.date2022-07-07T15:55:40Z
dc.date2015
dc.date.accessioned2023-08-23T00:06:18Z
dc.date.available2023-08-23T00:06:18Z
dc.identifier1140553
dc.identifier1140553
dc.identifierhttps://hdl.handle.net/10533/228546
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8353810
dc.descriptionThe ability of dendritic cells (DCs) to initiate and modulate antigen-specific immune responses has made them attractive targets for immunotherapy. Since DC research in humans is limited by the scarcity of DC populations in the blood circulation, most of
dc.descriptionRegular
dc.descriptionFONDECYT
dc.descriptionFONDECYT
dc.languageeng
dc.relationhandle/10533/111556
dc.relationhandle/10533/111541
dc.relationhandle/10533/108045
dc.relationhttps://www.frontiersin.org/articles/10.3389/fimmu.2015.00528/full
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleGene expression profiling of human monocyte-derived dendritic cells - searching for molecular regulators of tolerogenicity.
dc.titleFrontiers in Immunology
dc.typeArticulo
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución